The U.S. Food and Drug Administration today allowed marketing of the first cerebrospinal fluid (CSF) nucleic acid-based test for simultaneous detection of multiple pathogens that can cause central nervous system infections.
Category Archives: Food Safety News
Whole Foods Market Voluntarily Recalls All Cut, Wrapped And Weighed Papillon Organic Roquefort Cheeses Because Of Possible Health Risk
Whole Foods Market is recalling cheese sold in all stores nationwide that came from its supplier because it has the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant women. Consumers should seek immediate medical care if they develop these symptoms.
Read The Complete Story!
Federal judge issues permanent injunction against South Dakota laser manufacturer
A federal judge in the U.S. District Court for the District of South Dakota yesterday granted the U.S. Food and Drug Administration a permanent injunction against 2035 Inc. and Robert “Larry” Lytle, doing business as QLasers PMA and 2035 PMA.
General Mills Issues Voluntary Recall Of Cheerios And Honey Nut Cheerios Cereal Produced At Its Lodi, California Location On Certain Dates
General Mills is voluntarily recalling several days of production of Cheerios and Honey Nut Cheerios cereal produced at its Lodi, California facility on certain dates in July of this year because of an undeclared allergen – wheat – with potential adverse health effects.
Read The Complete Story!
Snack Out Loud Foods Issues Allergy Alert On Undeclared Milk In Snack Out Loud Sea Salt Crunchy Bean Snacks 1.2oz Single Serve Units
Snack Out Loud Foods today announced a recall of 56 cases of Sea Salt Crunchy Bean Snacks labeled with the lot number 63361, UPC 760055900037, Expiration Date 7/9/2016. This recall has been voluntarily initiated due to the possibility of Ranch product being packaged in Sea Salt single-unit serving film, which does not list milk as an allergen. Consumption of this product may cause an allergic reaction to milk. This recall will affect the entire lot identified.
Read The Complete Story!
FDA launches national public education campaign to prevent and reduce tobacco use among multicultural youth
The U.S. Food and Drug Administration today announced the launch of a national public education campaign to prevent and reduce tobacco use among youth who identify with the hip-hop peer crowd ‒ a hard-to-reach group that is frequently exposed to pro-tobacco images and messages. The FDA’s new campaign, “Fresh Empire,” is designed to reach the approximately 6 million multicultural youth ages 12–17, specifically African American, Hispanic, and Asian American/Pacific Islander youth, who are open to smoking or are already experimenting with cigarettes.
FDA approves new injectable drug to treat schizophrenia
On October 5, the U.S. Food and Drug Administration approved Aristada (aripiprazole lauroxil) extended release injection to treat adults with schizophrenia. Aristada is administered by a health care professional every four to six weeks using an injection in the arm or buttocks.
FDA approves expanded indication for medical device to treat a form of brain cancer
The U.S. Food and Drug Administration today approved an expanded indication for the Optune device to treat patients with newly-diagnosed glioblastoma multiforme (GBM), an aggressive form of brain cancer. It is given along with the chemotherapy drug temozolomide (TMZ) following standard treatments that include surgery, chemotherapy, and radiation therapy.
FDA approves expanded indication for medical device to treat a form of brain cancer
The U.S. Food and Drug Administration today approved an expanded indication for the Optune device to treat patients with newly-diagnosed glioblastoma multiforme (GBM), an aggressive form of brain cancer. It is given along with the chemotherapy drug temozolomide (TMZ) following standard treatments that include surgery, chemotherapy, and radiation therapy.
FDA orders duodenoscope manufacturers to conduct postmarket surveillance studies in health care facilities
The U.S. Food and Drug Administration today ordered the three manufacturers of duodenoscopes marketed in the U.S. to conduct postmarket surveillance studies to better understand how the devices are reprocessed in real-world settings.